OVID THERAPEUTICS INC.

Analyst Reco. Ovid Therapeutics Inc.

Equities

OVID

US6904691010

Market Closed - Nasdaq Other stock markets 16:30:01 2024-05-03 EDT			5-day change	1st Jan Change
3.06 ^USD	-0.33%		-1.29%	-4.97%

04-30	B. Riley Securities Initiates Ovid Therapeutics With Buy Rating, $9 Price Target	MT
04-29	HC Wainwright Starts Ovid Therapeutics With Buy Rating, $9 Price Target	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

B. Riley Securities Initiates Ovid Therapeutics With Buy Rating, $9 Price Target	04-30	MT
HC Wainwright Starts Ovid Therapeutics With Buy Rating, $9 Price Target	04-29	MT
BTIG Initiates Ovid Therapeutics With Buy Rating, Price Target is $11	12-21	MT
Oppenheimer Initiates Coverage on Ovid Therapeutics With Outperform Rating, $8 Price Target	23-10-13	MT
JonesTrading Initiates Ovid Therapeutics at Buy With $6 Price Target	23-06-14	MT
Citigroup Adjusts Ovid Therapeutics' Price Target to $2.40 from $4, Keeps Neutral Rating	22-05-20	MT
OVID THERAPEUTICS : Citigroup Adjusts Ovid Therapeutics' Price Target to $4 from $4.50, Keeps Neutral Rating	21-08-25	MT
OVID THERAPEUTICS : Cantor Fitzgerald Downgrades Ovid Therapeutics to Neutral from Overweight, Adjusts PT to $4 from $8	21-04-20	MT
OVID THERAPEUTICS : RBC Cuts Price Target on Ovid Therapeutics to $4 From $5, Maintains Rating at Sector Perform, Speculative Risk	21-04-20	MT
OVID THERAPEUTICS : Ladenburg Thalmann Adjusts Price Target on Ovid Therapeutics to $7 From $21, Maintains Buy Rating	20-12-02	MT
OVID THERAPEUTICS : RBC Capital Adjusts Ovid Therapeutics PT to $5 From $17, Maintains Outperform - Speculative Risk Rating	20-12-02	MT
OVID THERAPEUTICS : Citigroup Downgrades Ovid Therapeutics to Neutral From Buy, Adjusts Price Target to $4 From $10	20-12-02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer